ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Bears Pile Into MiniMed and SpaceX; Chewy Shorts Retreat

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Short sellers made bold moves this week. Data as of September 24 tells a striking story of divergence.

Biggest new short target: MMED. MiniMed Group saw its SI % of Free Float jump from 38.5% to 68.3% in just seven days — a 29.8 percentage point surge. With only 2.3% availability of short interest remaining, borrowing new shares is nearly impossible. Cost to borrow sits at 18.2%. A squeeze could ignite fast.

SpaceX stays in the crosshairs. SPCX short interest climbed to 30.6% of free float, up 9.8 points on the week. Bears remain committed despite a $1.2 trillion market cap. Availability is loose at 159%, so new shorts can still get in.

WOLF stays extreme. Wolfspeed carries 80.4% short interest. Zero shares are available to borrow. Any positive catalyst could send this semiconductor name sharply higher.

LUCK under pressure. Lucky Strike Entertainment carries a ORTEX short score of 94.8 and 30.6 days to cover. Cost to borrow hit 32.8%. Bears are paying a steep price to stay short.

Chewy shorts covered. CHWY SI fell from 74.1% to 67.2% over the week. Still very high, but the directional shift matters. 433% availability suggests ample shares remain if bears want back in.

Chip headlines dominate the news cycle, with the S&P 500 and Nasdaq closing lower as semiconductor stocks remain volatile.

Stocks in this article

How this article was generated

Generated
26 Sept 2026, 00:02
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilization

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.